Vir Biotechnology, Inc. (VIR)
10.71
+0.80
(+8.07%)
USD |
NASDAQ |
Aug 25, 16:00
10.80
+0.09
(+0.84%)
After-Hours: 19:59
Vir Biotechnology Market Cap : 1.812B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 1.812B |
| August 24, 2026 | 1.677B |
| August 21, 2026 | 1.655B |
| August 20, 2026 | 1.558B |
| August 19, 2026 | 1.653B |
| August 18, 2026 | 1.606B |
| August 17, 2026 | 1.589B |
| August 14, 2026 | 1.563B |
| August 13, 2026 | 1.523B |
| August 12, 2026 | 1.516B |
| August 11, 2026 | 1.511B |
| August 10, 2026 | 1.504B |
| August 07, 2026 | 1.492B |
| August 06, 2026 | 1.483B |
| August 05, 2026 | 1.541B |
| August 04, 2026 | 1.551B |
| August 03, 2026 | 1.506B |
| July 31, 2026 | 1.396B |
| July 30, 2026 | 1.435B |
| July 29, 2026 | 1.393B |
| July 28, 2026 | 1.427B |
| July 27, 2026 | 1.419B |
| July 24, 2026 | 1.401B |
| July 23, 2026 | 1.506B |
| July 22, 2026 | 1.508B |
| Date | Value |
|---|---|
| July 21, 2026 | 1.519B |
| July 20, 2026 | 1.488B |
| July 17, 2026 | 1.520B |
| July 16, 2026 | 1.516B |
| July 15, 2026 | 1.549B |
| July 14, 2026 | 1.530B |
| July 13, 2026 | 1.567B |
| July 10, 2026 | 1.606B |
| July 09, 2026 | 1.667B |
| July 08, 2026 | 1.682B |
| July 07, 2026 | 1.653B |
| July 06, 2026 | 1.616B |
| July 02, 2026 | 1.619B |
| July 01, 2026 | 1.541B |
| June 30, 2026 | 1.643B |
| June 29, 2026 | 1.674B |
| June 26, 2026 | 1.617B |
| June 25, 2026 | 1.593B |
| June 24, 2026 | 1.604B |
| June 23, 2026 | 1.638B |
| June 22, 2026 | 1.543B |
| June 18, 2026 | 1.477B |
| June 17, 2026 | 1.499B |
| June 16, 2026 | 1.388B |
| June 15, 2026 | 1.388B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Caribou Biosciences, Inc. | 186.55M |
| Arrowhead Pharmaceuticals, Inc. | 12.54B |
| Oncolytics Biotech, Inc. | 107.36M |
| Sangamo Therapeutics, Inc. | 61.69M |
| Sarepta Therapeutics, Inc. | 1.998B |
Market Cap Related Metrics
| PS Ratio | 5.248 |
| Price to Book Value | 1.844 |
| Price | 10.71 |
| Earnings Yield | -17.38% |